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Clinical	Decision-Making	at	the	End	of	Life:		A	Mixed	Methods	Study	
	
	
	
Structured	Abstract	
	
Objectives:		
	
To	improve	the	ability	of	clinical	staff	to	recognise	end-of-life	in	hospital	in-patients	
dying	as	a	result	of	cancer	and	heart	failure,	and	to	generate	new	hypotheses	for	further	
research.	
	
Methods:		
	
This	mixed-methods	study	used	decision	theory	as	a	theoretical	basis.		It	involved	a	
parallel	databases-convergent	design,	incorporating	findings	from	previously	published	
research,	with	equal	priority	to	study	groups	and	synthesis	by	triangulation.	
	
The	individual	arms	were	(1)	a	retrospective	cohort	study	of	102	cancer	patients	and	81	
heart	failure	patients	in	an	acute	trust	in	the	North	of	England,	and	(2)	a	semi-
structured	interview	study	of	19	healthcare	professionals	caring	for	the	same	patient	
groups.	
	
Results:		
	
The	synthesis	of	findings	demonstrated	areas	of	agreement,	partial	agreement,	silence	
and	dissonance	when	comparing	the	cohort	findings	with	the	interview	findings.		
Trajectories	of	change	are	identified	as	associated	with	poor	prognosis	in	both	
approaches,	but	based	on	different	parameters.		Management	of	patients	has	a	
significant	impact	on	decision-making.		The	decision	process	requires	repeated,	
iterative	assessments	and	may	benefit	from	a	multi-disciplinary	approach.		Uncertainty	
is	a	defining	characteristic	of	the	overall	process,	and	objective	parameters	only	have	a	
limited	role	in	predicting	end	of	life.	
	
Conclusions:		
	
The	role	of	uncertainty	is	important	as	a	trigger	for	discussions	and	a	defined	stage	in	a	
patient’s	illness	journey.	This	is	consistent	with	current	approaches	to	recognising	
irreversible	deterioration	in	those	with	serious	illness.		This	study	contributes	ongoing	
evidence	that	these	concepts	are	vital	for	decision-making.	
	
	
	
	
	
	
	
Background.	
	
	
The		implementation	of	good	care	of	the	dying	depends	on	the	recognition	that	a	person	
is	in	their	final	days	(1).		Timely	recognition	of	dying	allows	appropriate	
implementation	of	symptom	measures,	whilst	minimising	unnecessary	invasive	and	
costly	interventions	(2).		In	the	USA,	appropriate	recognition	of	end-stage	disease	
allows	hospice	care	to	be	delivered	via	benefits	comparable	with	Medicare	(public	
health	insurance	for	the	over-65s),	with	consequent	improvement	in	symptom	control	
and	quality	of	life	(3).		From	the	earliest	days	of	medical	practice(4),	to	the	preferences	
of	patients	and	their	families	(5),	through	to	recent	recommendations	on	palliative	care	
research	topics	(6),	the	recognition	of	dying	features	as	a	vital	topic.	
	
Despite	the	centrality	of	this	skill	to	palliative	care,	the	key	findings	from	primary	
research	continue	to	reinforce	that	the	task	is	challenging,	with	recent	national	
guidance	recommending	research	into	the	recognition	of	dying	as	a	priority(7).	A	
simple	single-question	tool,	the	“surprise	question”,	remains	one	of	the	leading	
techniques	for	recognising	the	last	six	months	to	a	year	of	life	(8),	yet	demonstrates	a	
wide	variation	in	accuracy	when	applied	to	different	contexts,	patient	populations,	
timescales	or	by	different	professionals	(9).		Ongoing	research	approaches	include	using	
case	vignettes	to	model	the	accuracy	of	clinician’s	decisions	(10),	using	audit	data	to	
explore	the	timing	of	the	decision	(11),	using	routine	data	to	model	the	biology	of	
dying(12),	using	prognostic	methods	at	a	short	time	scale	(13),	and	using	qualitative	
methods	to	explore	decision	processes	(14).		An	integrative	review	of	the	literature	has	
reinforced	the	inherent	difficulty	and	uncertainty	in	this	process,	and	the	breadth	of	
research	techniques	with	which	it	can	be	explored	(2).	
	
Theories	of	Clinical	Decision-Making	provide	a	framework	for	understanding	these	
processes.		Whilst	a	number	of	models	exist,	they	can	largely	be	understood	as	fitting	
into	one	of	three	categories;	normative,	prescriptive	or	descriptive	(15).		Normative	
models	use	mathematical	and	probabilistic	techniques	to	outline	an	idealised	decision.		
Prescriptive	models	produce	tools	to	enable	practitioners	to	translate	normative,	
“idealised”	decisions	into	practice.		Descriptive	models	explore	the	processes	by	which	
decision-makers	act	in	practice	(16).	
	
None	of	these	categories	is	inherently	superior	to	the	others.		Normative	models	
translate	real-world	data	into	meaningful	information,	prescriptive	models	take	this	
information	and	generate	outputs	which	are	clinically	applicable,	and	descriptive	
models	explore	the	boundary	between	these	idealised,	rational	predictions	and	the	real-
world	decisions	and	actions	taken	by	human	practitioners	(16).		Therefore,	by	
undertaking	a	study	in	which	two	or	more	approaches	are	combined,	we	can	come	to	a	
greater	understanding	of	the	decision	in	question	within	the	framework	of	decision	
theory.	
	
This	article	reports	on	the	findings	of	a	mixed-methods	study	where	the	individual	arms	
have	already	been	reported	(17–19).		The	a	priori	design	was	of	post-completion	
synthesis,	which	allowed	two	distinct	decision-making	approaches	to	be	combined	into	
a	single	study.		By	publishing	the	studies	in	sequence	and	focusing	on	the	synthesis	
here,	we	allow	each	one	to	contribute	to	the	research	base	on	its	own	terms,	maximise	
transparency	and	allow	a	detailed	discussion	of	the	mixed-methods	synthesis	as	a	study	
in	its	own	right.	
	
The	aim	of	this	mixed-methods	study	was	to	explore	the	ability	of	clinical	staff	to	
recognise	end	of	life	in	hospital	in-patients	dying	as	a	result	of	cancer	and	heart	failure,	
and	to	generate	new	hypotheses	for	further	research.	
	
Methods	
	
Study	design	
	
This	mixed-methods	study	combined	a	retrospective	cohort	study	and	a	qualitative		
interview	study.		Detailed	descriptions	of	the	methods	are	available	elsewhere.(17–19)	
	
The	retrospective	cohort	study	was	planned	as	a	normative	approach	to	decision-
making,	using	physiological	data	to	model	the	biology	of	the	dying	process.		It	involved	
extracting	routinely	collected	physiological	data	covering	the	final	two	weeks	(three	
months	for	certain	variables)	of	life	from	healthcare	records.		Data	was	collected	on	
patients	with	heart	failure	(n=81)	(19)and	cancer	(n=102)	(17).		Multilevel	modelling	
was	used	to	explore	evidence	for	change	in	these	parameters	as	death	approached.		
Results	were	reported	separately	for	each	condition.			
	
The	qualitative	study	was	planned	as	a	descriptive	approach	to	decision-making	
research,	using	interviews	to	understand	the	processes	by	which	professionals	make	
these	decision	in	the	real	world.		It	involved	undertaking	semi-structured	interviews	
with	medical	and	nursing	staff	sampled	according	to	three	levels	of	seniority	and	
experience.		The	interviewees	were	drawn	from	cardiology	or	oncology	in-patient	
services.		A	total	of	11	oncology	staff	(6	doctors,	5	nurses)	and	8	cardiology	staff	(3	
doctors,	5	nurses)	were	included.		Findings	were	analysed	using	thematic	analysis	
according	to	Braun	and	Clarke’s	methodology	(20).		
	
Data	from	each	arm	was	collected	separately,	and	synthesis	took	place	only	after	both	
analyses	were	completed;	a	parallel	databases-convergent	design	(21).		Each	arm	of	the	
study	was	interpreted	against	the	findings	of	the	other,	so	that	each	set	of	results	was	
used	to	critique	and	appraise	the	findings	of	the	other.		In	combining	these	findings	in	
this	study,	the	approach	was	broadly	qualitative.		The	findings	from	the	interview	study	
were	thematic	and	hence	a	quantitative	synthesis	was	not	appropriate.			
	
Setting		
	
The	setting	for	both	arms	was	an	acute	National	Health	Service	(NHS)	hospital	trust	in	
the	North	of	England,	which	is	a	tertiary	referral	centre	for	both	oncology	and	
cardiology.	
	
Ethics	
	
Ethical	approval	was	obtained	separately	for	the	individual	arms	of	the	study,	and	
approved	by	an	NHS	Research	Ethics	Committee	(Ref	10/H1304/18;	10/H1304/70).		
Research	governance	aspects	were	addressed	by	the	University	Research	Governance	
Committee,	in	conjunction	with	PhD	supervision	and	advisory	panels.		The	hosting	trust	
provided	R&D	approval.		The	National	Information	Governance	Board	provided	
approval	regarding	information	governance	aspects	of	the	cohort	study.	
	
Analysis	
	
The	synthesis	was	undertaken	by	one	of	the	researchers	(PT),	with	iterative	discussion	
and	reviewing	of	the	generated	concepts	at	all	stages	of	the	work	by	the	other	authors	
(MJ,	DD),	each	of	whom	has	experience	in	the	respective	study	methods.		The	analysis	
process	used	for	the	mixed-methods	synthesis	was	triangulation,	which	involved	cross-
referencing	the	research	findings	for	areas	of	agreement,	partial	agreement,	dissonance	
and	silence	(22).		
	
In	this	analysis,	agreement	is	recorded	where	the	interview	findings	describe	a	
phenomenon	observed	in	the	cohort	study.		Partial	agreement	exists	where	the	studies	
report	on	similar	phenomena,	but	cannot	be	uncritically	said	to	agree;	these	cases	are	
described	in-text.		Dissonance	occurs	where	the	studies	report	findings	which	are	
directly	contradictory.		This	further	relates	to	the	concept	of	“attention	to	deviant	
cases”;	an	important	aspect	of	qualitative	research;	any	areas	where	the	two	studies	
significantly	deviate	from	one	another	were	intended	to	be	reported	under	this	heading.		
Silence	occurs	where	one	study	makes	an	observation	on	which	the	other	does	not	
comment,	and	where	such	comment	could	be	expected.	
	
The	different	methods	used	in	this	synthesis	mean	that	there	will	necessarily	be	areas	
where	one	study	is	not	able	to	reflect	the	results	of	another.		For	example,	one	
participant	described	using	the	former	Liverpool	Care	Pathway	criteria	as	a	diagnostic	
tool,	whilst	the	cohort	study	would	not	be	able	to	provide	information	on	this	subject.		A	
degree	of	interpretation	is	therefore	necessary	when	comparing	the	two	arms.	
	
The	findings	in	the	cohort	study	were	initially	cross-referenced	with	instances	in	the	
interview	study	where	participants	described	objectively	defined	parameters,	or	where	
significant	omissions	occurred.		Following	this,	the	more	detailed	themes	and	analyses	
of	the	interview	study	were	cross-referenced	with	the	interpretation	of	the	cohort	
study,	to	determine	whether	these	themes	were	supported	in	both	cases.		Neither	study	
was	accorded	priority	in	the	analysis.		The	process	is	summarised	in	a	flow	chart	in	
figure	1.	
	
Results	
	
Cohort	study	summary	
	
In	both	patient	populations	(17,19),	respiratory	and	renal	function	deteriorated	in	the	
final	two	weeks	of	life,	whilst	serum	albumin	deteriorated	over	a	timescale	of	three	
months.		White	cell	count	rose	in	cancer,	but	did	not	show	statistically	significant	
change	in	heart	failure.		Heart	rate	and	serum	sodium	showed	a	statistically	significant	
increase,	but	with	limited	clinical	significance,	in	both	conditions.		Other	parameters	
(reported	in	tables	1	and	2	and	described	in	more	detail	in	the	synthesis)	were	assessed	
in	the	cohort	study	without	showing	evidence	of	statistically	significant	change.	
	
Interview	study	summary	
	
The	interview	study	generated	six	themes	and	thirteen	sub-themes,	with	defined	areas	
of	overlap	(18).		These	themes	and	sub-themes	are	listed	in	table	3.		One	theme	of	note	
in	the	study,	“information	used”,	was	the	basis	of	a	significant	part	of	the	triangulation	
of	the	cohort	study.		This	theme	defined	objective	pieces	of	information	used	by	clinical	
staff	as	part	of	the	decision	process.		Other	themes	are	reported	here	to	the	extent	that	
they	required	triangulation	with	the	cohort	study.	
	
Defined	characteristics	of	the	decision	process	as	a	whole	were	identified.		It	was	fluid,	
in	that	the	distinction	between	active	management	and	recognition	of	dying	was	
blurred.		It	was	ongoing,	as	decision-makers	described	using	information	acquired	over	
a	period	of	time.		It	was	iterative,	as	the	process	involves	a	continuous	reappraisal	of	the	
decision	in	the	light	of	changing	information.		These	findings	supported	the	fact	that	the	
decision	process	involves	a	degree	of	intuition	and	pattern	recognition,	integrated	with	
objective	measures,	which	is	consistent	with	the	dual-process	theory	of	clinical	
reasoning	(23).	
	
Mixed-methods	synthesis	
	
Triangulating	cohort	data	against	interview	data.	
	
To	ensure	a	meaningful	comparison,	the	qualitative	data	used	at	this	point	in	the	
synthesis	is	limited	to	interview	participants	describing	phenomena	which	relate	to	
objectively	measurable	characteristics;	these	phenomena	had	been	incorporated	into	a	
single	theme	in	the	qualitative	study	(“Information	Used”).		
	
These	findings	were	directly	compared	with	the	results	of	the	cohort	study;	for	each	
finding	which	demonstrated	a	statistically	and/or	clinically	significant	change	in	the	
final	two	weeks	of	life,	the	list	of	objective	measures	derived	from	the	theme	
“Information	Used”	was	searched	for	related	measures.		Note	that	qualitative	findings	
were	not	limited	to	absolute	values,	but	also	to	interpretation	of	data	and	rate	of	change	
information.		The	findings	are	summarised	in	table	1	(cancer)	and	2	(heart	failure).	
	
Agreement	
	
Agreement	was	demonstrated	between	the	studies	where	the	cohort	demonstrated	
tachypnoea,	hypoxia,	raised	urea	and	creatinine,	whilst	the	respondents	in	the	
interview	study	described	using	the	same	parameters,	or	used	related	terms	such	as	
“breathlessness”	and	“renal	dysfunction”.		This	agreement	was	preserved	across	both	
cancer	and	heart	failure	patients.		In	addition,	raised	white	cell	count	demonstrated	
agreement	between	the	studies	for	cancer	patients.	
	
Partial	agreement	
	
For	areas	of	partial	agreement	for	cancer	patients,	falling	haemoglobin	and	albumin	
were	associated	with	poor	prognosis	and	reported	as	such	in	the	interview	study.		
However,	the	cohort	findings	only	demonstrated	statistical	significance	over	a	timescale	
of	three	months,	therefore	limiting	their	role	in	the	recognition	of	dying	other	than	
providing	a	context	of	deterioration	over	this	time	period.			
	
In	both	cancer	and	heart	failure,	rising	heart	rate	and	rising	serum	sodium	showed	
statistically	significant	change	in	the	final	two	weeks	of	life,	but	without	clinical	
significance;	both	observations	were	reported	in	the	interview	study	for	heart	failure	
patients;	neither	were	reported	for	cancer	patients.		The	borderline	high	white	cell	
count	in	heart	failure	patients	suggests	a	further	possible	area	of	agreement	between	
the	studies.	
	
Dissonance	
	
An	area	of	explicit	dissonance	for	both	patient	groups	was	blood	pressure.		The	cohort	
study	showed	no	association	between	blood	pressure	changes	and	approaching	death,	
yet	participants	in	the	interview	study	reported	hypotension	as	sought	information.		In	
cancer,	a	further	area	of	dissonance	occurred	where	a	single	participant	described	
bradycardia	as	significant,	contrasting	directly	with	the	cohort	findings.	
	
Silence	
	
Here,	silence	is	defined	as	cases	in	which	one	arm	highlighted	a	factor	as	significant,	the	
other	arm	contained	insufficient	information	to	allow	a	comparison,	and	where	such	a	
comparison	would	be	meaningful.	These	are	outlined	in	the	table	summary.		Other	
characteristics	not	suitable	for	this	type	of	comparison	are	reported	in	the	original	
papers.	
	
Triangulating	interview	data	against	cohort	data.	
	
In	triangulating	the	findings	further,	and	ensuring	each	study	is	treated	equally,	a	
number	of	more	detailed	concepts	highlighted	in	the	qualitative	study	may	be	defined	
and	critiqued	in	terms	of	the	findings	of	the	cohort	study.		This	also	involved	searching	
for	agreement,	partial	agreement,	silence	and	dissonance.		The	nature	of	the	findings	
reported	in	the	interview	study	required	a	degree	of	critical	interpretation	of	the	cohort	
findings	and	justification	of	the	link;	this	is	outlined	below.		There	were	no	new	areas	of	
dissonance	or	silence	highlighted	in	this	section.	
	
Agreement	
	
The	first	area	of	agreement	was	the	impact	of	patient	management	on	assessment.		In	
the	interview	study,	participants	were	asked	to	describe	their	decision	processes	with	
reference	to	a	specific	patient	case,	and	then	to	generalise	to	the	wider	context	of	
recognising	dying.		One	observation	arising	from	the	interviews	was	a	tendency	for	
participants	to	mix	responses	on	recognising	dying,	managing	dying	and	treating	acute	
illness.		In	some	cases,	a	participant	would	explicitly	describe	observing	a	patient’s	
response	to	treatment	as	part	of	their	decision	process.		In	others,	discussion	of	
common	symptoms	indicating	the	final	days	of	life	were	combined	with	a	discussion	on	
how	such	symptoms	should	be	managed.	
	
The	implication	of	this	is	that	the	processes	by	which	dying	is	recognised	cannot	be	
clearly	separated	from	the	processes	of	clinical	care	which	take	place	at	the	same	time.		
In	the	cohort	study,	this	observation	is	reinforced	by	the	fact	that	certain	parameter	
values,	demonstrated	as	associated	with	poor	prognosis,	had	the	potential	to	change	as	
a	result	of	medical	treatment.	A	key	example	is	the	masking	of	deteriorating	oxygen	
levels	in	the	light	of	access	to	prescribed	oxygen.	
	
The	second	area	of	agreement	was	the	importance	of	repeated,	iterative	assessments,	
which	was	one	of	the	key	characteristics	of	the	decision	process	outlined	in	the	
interview	study.		Given	that	time-dependent	change	is	shown	(both	in	the	literature	
(24)	and	in	this	study)	to	be	important,	single	measures	of	a	person’s	physiology	are	
less	useful	than	sequential	measures.		In	outlining	the	impact	of	patient	management	on	
assessment,	it	is	clear	that	the	decision	process	requires	an	iterative	approach,	
developing	as	a	result	of	change	over	time	and	change	in	response	to	intervention.			
	
Each	of	these	concepts	is	borne	out	by	a	detailed	assessment	of	the	cohort	data.		Whilst	
the	multilevel	models	demonstrate	evidence	of	common	change	in	certain	parameters	
at	the	population	level,	there	was	significant	variation,	even	within	individuals.		
Whether	this	heterogeneity	represented	genuine	clinical	fluctuations	(e.g.	acute	
deterioration),	effect	of	management	(e.g.	treating	hypoxia	with	oxygen),	measurement	
error	or	a	further	confounding	factor	is	not	clear.		Nevertheless,	this	finding	cautions	
against	aiming	to	rely	on	a	single	one-off	assessment	when	recognising	dying.			
	
Partial	agreement	
	
The	importance	of	“patterns	of	change”	was	a	sub-theme	in	the	qualitative	study,	which	
contributed	to	one	of	the	key	themes	and	the	subsequent	analysis.		Participants	
described	observing	how	a	patient’s	condition	changes	over	time;	the	cohort	study	(and	
literature	review)	agreed	with	this	observation	by	demonstrating	that	rate	of	change	is	
associated	with	prognosis.			
	
However,	interview	participants	typically	described	rate	of	change	in	terms	of	general	
measures	such	as	performance	status,	rather	than	individual	parameters;	the	cohort	
study	did	not	obtain	sufficient	information	on	performance	status	to	facilitate	an	
analysis,	but	did	highlight	the	importance	of	patterns	of	change	on	other	parameters.		
Whilst,	therefore,	the	concept	of	rate	or	pattern	of	change	is	an	area	of	agreement	
between	the	study	arms,	there	is	only	partial	agreement	in	the	areas	to	which	it	applies.		
This	highlights	that	there	is	some	uncertainty	in	the	decision	process,	and	some	limit	to	
the	perceived	value	of	observations	in	assessing	the	dying	patient.		
	
The	final	area	of	partial	agreement	was	“knowledge	of	the	patient”.	With	the	above	
discussion	highlighting	the	importance	of	repeated	assessments,	it	might	be	assumed	
that	increased	familiarity	with	the	patient	would	enhance	the	ability	of	a	clinician	to	
recognise	approaching	death.		This	was	not	necessarily	supported	by	the	interview	data.	
For	example,	a	staff	member	reviewing	a	patient	daily	may	notice	a	discrete	change,	but	
may	miss	a	subtle,	gradual	change	over	a	longer	time	period.		Differences	in	frequency	
of	patient	review	were	related	to	profession	(nurses	having	more	frequent	contact	than	
doctors)	and	seniority	(junior	staff	having	more	frequent	contact	than	seniors),	
suggesting	that	a	multi-disciplinary	approach	would	be	valuable.	
	This	evidence	is	reflected	in	the	cohort	study	in	that	different	parameters	exhibit	
change	over	different	timescales,	with	respiratory	dysfunction	exhibiting	the	most	rapid	
change	with	day-on-day	deterioration,	whilst	albumin/haemoglobin	deteriorate	much	
more	slowly,	showing	significant	change	over	weeks.	
	
Discussion	
		
This	synthesis	reinforces	findings	identified	in	both	arms,	adding	context	to	the	results	
presented	in	those	papers.		The	key	findings	to	which	this	reinforcement	applies	are:	(1)	
That	time-dependent	information	is	important	and	belies	an	iterative	decision	process,	
(2)	that	the	distinction	between	managing	and	recognising	dying	is	blurred,	(3)	that	
repeated	assessments	by	professionals	are	a	key	component	of	the	decision	process	as	a	
whole,	(4)	that	clinical	observations	do	not	provide	the	entirety	of	relevant	data	for	the	
decision,	and	(5)	that	uncertainty	is	a	significant	and	arguably	unavoidable	component	
of	the	process.	
	
The	importance	of	time-dependent	information	is	strongly	reported	in	both	studies	and	
reflects	findings	in	the	research	literature.		The	association	between	prognosis	and	rate	
of	change	of	performance	status	was	highlighted	as	early	as	2000	(24),	whilst	a	seminal	
qualitative	work	highlighted	the	importance	of	understanding	the	disease	trajectory	for	
end	of	life	care(25).	and	has	recently	acquired	further	attention;	a	detailed	literature	
review	exploring	the	biology	of	dying	focuses	on	changes	in	parameter	values,	rather	
than	solely	on	absolute	levels(12).	
	
The	overlap	between	management	and	assessment	is	interesting,	rooted	most	strongly	
in	the	qualitative	data	and	supported	in	the	cohort	studies.		The	fact	that	the	recognition	
that	a	person	is	dying	may,	in	part,	rely	on	response	to	treatment,	blurs	the	distinction	
between	“active”	management	and	end	of	life	care.			
	
The	importance	of	repeated,	iterative	assessments	relates	to	both	of	the	above	
observations	and	is	supported	equally	by	both	studies.		A	professional	must	undertake	
sequential	assessments	in	order	properly	to	understand	a	pattern	or	rate	of	change,	and	
must	review	effects	of	prior	management	plans	in	order	to	assess	ongoing	response	to	
repeated	treatments	and	review	their	diagnosis.	
	
The	limited	role	of	clinical	observations	in	the	decision	process	is	supported	in	both	
studies	and	further	evidenced	by	the	overall	synthesis	of	findings.		Both	the	qualitative	
and	quantitative	studies	highlighted	that	observations	and	bedside	parameters	were	
useful	pieces	of	information,	but	limited	in	their	application;	those	parameters	
highlighted	as	potentially	useful	in	each	separate	arm	do	not	fully	overlap.		Interviewees	
described	relying	on	parameters	which	were	not	confirmed	as	useful	in	the	cohort	
study	or,	in	one	case,	stated	explicitly	that	observations	were	not	useful.		
	
Finally,	this	study	also	highlights	that	the	recognition	of	dying	appears	to	be	a	process	
characterised	by	uncertainty.		Whilst	this	conclusion	is	directly	described	in	the	
discussion	for	the	qualitative	study,	and	supported	by	the	cohort	findings,	it	also	
naturally	follows	from	the	observations	presented	above.		Rather	than	searching	for	a	
system	of	clinical	parameters	which	can	be	used	as	an	indicator	of	dying,	these	findings	
point	to	a	complex	and	involved	process,	with	ongoing	scope	for	error.		The	inherent	
uncertainty	and	time-dependent	nature	of	the	decision	process	with	highly	variable	
physiological	parameters	and	levels	of	involvement,	is	further	complicated	by	the	fact	
that	it	relies	partly	on	intuition;	a	characteristic	of	intuitive	decision-making	is	that	it	is	
difficult	to	describe.		The	existing	literature	also	supports	the	role	of	uncertainty	in	the	
decision	processes	in	end-of-life	care,	in	addition	to	the	potential	benefit	of	
communicating	this	uncertainty	to	patients	and	their	families	(14).			
	
This	latter	observation	relates	closely	to	two	current	UK	initiatives	in	palliative	care,	
which	are	the	subjects	of	ongoing	research.		These	are	the	AMBER	(Assessment,	
Management,	Best	practice,	Engagement,	Recovery	uncertain)	Care	Bundle	(26,27),	and	
the	phase	data	from	the	OACC		(Outcome	Assessment	and	Complexity	Collaborative)	
suite	of	measures	(28).		AMBER	is	a	prescriptive	decision-support	tool	for	use	in	
hospitals	when	the	possible	outcomes	of	a	patient’s	condition	are	uncertain	(29).		The	
OACC	suite	of	measures	includes	phase	data,	classifying	patient	management	plans	
according	to	whether	their	condition	is	stable,	unstable,	deteriorating	or	dying(30);	the	
unstable	phase	maps	closely	to	the	uncertainty	described	here.		Given	that	direct	studies	
aimed	at	validating	these	initiatives	are	still	being	conducted,	the	study	presented	here	
provides	further	support	for	their	value.	
	
Internationally,	there	is	a	significant	variation	in	the	provision	of	palliative	care.		
However,	the	appropriate	recognition	of	dying	links	directly	into	improved	patient	care;	
through	timely	use	of	appropriate	symptom	measures,	through	the	minimising	of	
invasive	(and	potentially	costly)	interventions	and	through	directing	patients	into	the	
appropriate	routes	of	service	as	the	soonest	opportunity	(31)	(32)(3).	
	
Conclusions	
	
Through	comparing	and	triangulating	data	from	two	distinct	studies	and	methods,	this	
mixed-methods	synthesis	has	reinforced	and	contextualised	the	findings	of	both	arms.		
This	has	added	further	insights	into	the	processes	by	which	medical	professionals	
recognize	and	make	decisions	for	dying	patients,	and	contributes	to	the	evidence	base	
for	initiatives	which	are	currently	undergoing	real-world	assessment.		
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Figure	1.		Overall	structure	of	study.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
		
	
	
	
	
	
	
	
	
	
Table	1.		Objective	factors	associated	with	poor	prognosis	in	cancer.	
Green	=	Full	agreement,	yellow	=	partial	agreement,	blue	=	silence	(where	a	finding	is	
identified	in	only	one	study),	red	=	dissonance	(where	study	findings	contradict	one	another)	
	
Nature	of	significance	in	
cohort	study	
Parameters	in	
cohort	study	
Description	in	interview	study,	under	
theme		“Sought	information”	
Statistically	and	clinically	
significant	association	
with	poor	prognosis	in	
final	two	weeks	of	life	
Increased	
respiratory	rate	
Reduced	oxygen	
saturation	
Increased	urea	and	
creatinine	
Raised	white	cell	
count	
Increased	respiratory	rate	
Breathlessness	
Increased	urea	and	creatinine	
Renal	function	
Raised	white	cell	count	
Demonstrated	
association	with	poor	
prognosis	over	longer	
timescales	
Falling	
haemoglobin	
Falling	albumin	
Haemoglobin		
Albumin	
Statistically	but	not	
clinically	significant	
association	with	poor	
prognosis	
	
Raised	heart	rate	
Increased	sodium	
	
Not	described	in	this	population	
Others	 Not	sought	or	
obtained	in	this	
population	
Temperature		
Early	Warning	
Score	
Chest	drain	output	
Imaging	
CRP	
Blood	cultures	
ECG	
Performance	status	
â
Weight	â	
Confusion		
Nausea/vomiting	â	
Urine	output	
Analgesic	use	á	
No	evidence	of	
association	
Blood	pressure	
Falling	heart	rate	
Blood	pressure	
Bradycardia	
	
	
	
		
	
	
	
	
	
	
	
	
	
Table	2.		Objective	factors	associated	with	poor	prognosis	in	heart	failure.	
Green	=	Full	agreement,	yellow	=	partial	agreement,	blue	=	silence	(where	a	finding	is	
identified	in	only	one	study),	red	=	dissonance	(where	study	findings	contradict	one	another)	
	
Nature	of	significance	in	
cohort	study	
Parameters	in	cohort	study	 Description	in	interview	study,	
under	theme		“Sought	
information”	
Statistically	and	clinically	
significant	association	with	
poor	prognosis	in	final	two	
weeks	of	life	
Increased	respiratory	rate	
Reduced	oxygen	saturation	
Increased	urea	and	
creatinine	
Increased	respiratory	rate	
Breathlessness	
Increased	urea	and	creatinine	
Renal	function	
Clinically	abnormal	values	
suggest	possible	association	
with	poor	prognosis	over	
longer	timescales		
	
Raised	white	cell	count		 Raised	white	cell	count		
	
Statistically	but	not	clinically	
significant	association	with	
poor	prognosis	
	
Increased	heart	rate	
Increased	serum	sodium	
Increased	heart	rate	
Increased	serum	sodium	
Demonstrated	association	
with	poor	prognosis	over	
longer	timescales		
	
Falling	albumin	 Not	described	in	this	
population	
Clinically	abnormal	values	
suggest	possible	association	
with	poor	prognosis	over	
longer	timescales	
	
Falling	lymphocyte	count	 Not	described	in	this	
population	
Others	 Not	sought	or	obtained	 NYHA	class		
á	
Weight	
change	
Urine	
output	â	
Echo-estimated	
LVEF	â	
Confusion		?	
	
No	evidence	of	association	 Blood	pressure	 Blood	pressure	
		
Table	3.		Summary	of	themes	and	sub-themes	in	interview	study.		The	detail	of	these	
themes	is	explored	further	in	the	source	article.		The	triangulation	with	the	cohort	study	is	
discussed	in	the	results	section.		Concepts	outlined	in	bold	text	are	referenced	explicitly	in	
the	study	text.	
	
	
Sub-themes	
	
Themes	
Limits	of	interventions	
Knowledge	of	the	
patient	
Managing	dying	
Sought	information	
Existing	interventions	
Patterns	of	change	
	
Pathological	processes	
General	factors	
Patient	perspective	
Professional	factors	
Interactions	with	
patients	and	carers	
Interactions	with	
professionals	
Individual	processes	
	
Information	used	
Implementation	
Modifying	factors	
Decision	processes	
Reflecting	on	decisions	
Related	decisions	
	
	
	
